ASTHMAXcel Voice Study
Recruiting · NCT06935084 · Interventional (participants receive a specific treatment) · Lead sponsor: Montefiore Medical Center
View the official record on ClinicalTrials.gov →Interventions studied
ASTHMAXcel Voice platform
What this trial is about
The objective of this study is to conduct a randomized controlled trial (RCT) to compare the adapted and refined ASTHMAXcel Voice platform to usual care (UC). It is hypothesized by the investigator team that ASTHMAXcel Voice will be associated with improved clinical and process outcomes, asthma quality of life (QOL), medication adherence, and self-efficacy as compared to UC.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- English speaking
- Persistent asthma (diagnosed by a healthcare provider) on a daily controller medication
- Able to provide informed consent
- Smartphone access (iOS or Android) with data plan
Exclusion criteria
- Pregnancy
- Severe psychiatric or cognitive problems that would prohibit completion of protocol
Where it is running
1 location listed across 1 US state.
- Montefiore Medical Center - The Bronx, New York, United States